Ҵý

Feature Channels: Epilepsy

Filters close
Go to Advanced Search
Released: 2-May-2025 12:05 AM EDT
Medicaid Unwinding Disrupted Kids’ and Young Adults’ Access to Chronic Disease Medicine
Michigan Medicine - University of Michigan

A new study suggests that medication interruptions among children and young adults taking medicine for chronic conditions happened more often in states that had the biggest drops in Medicaid enrollment during the recent “unwinding” process.

Ҵý: The International League Against Epilepsy Updates Classification of Epileptic Seizures
Released: 23-Apr-2025 8:40 AM EDT
The International League Against Epilepsy Updates Classification of Epileptic Seizures
International League Against Epilepsy

The International League Against Epilepsy (ILAE) has updated the operational classification of epileptic seizures, building upon the framework published in 2017. Six key changes were made. The updated classification now consists of four main classes and 21 seizure types, compared with 63 types previously.

Released: 22-Apr-2025 9:55 AM EDT
Seizure Action Plans: Management and Educational Tools in Epilepsy Care
International League Against Epilepsy

Historically, seizure action plans have focused on certain high-risk groups of people with epilepsy. But some clinicians say that seizure action plans are important educational and seizure management tools that should be offered to everyone.

Ҵý: Plans d'action en cas de crise : plus que des outils de prise en charge de l'épilepsie
Released: 22-Apr-2025 9:40 AM EDT
Plans d'action en cas de crise : plus que des outils de prise en charge de l'épilepsie
International League Against Epilepsy

Historiquement, les plans d'action lors de la prise en charge d’une crise se sont concentrés sur certains groupes de patients à haut risque, tels que les personnes atteintes d'épilepsie résistante aux médicaments et les personnes ayant des antécédents d'état de mal épileptique ou de crises subintrantes.

Ҵý:Video Embedded two-brain-proteins-are-key-to-preventing-seizures-research-in-flies-suggests
VIDEO
Released: 21-Apr-2025 1:00 PM EDT
Two Brain Proteins are Key to Preventing Seizures, Research in Flies Suggests
University of Utah Health

One in ten people will have a seizure in their life, but treatments remain limited, in part due to incomplete understanding of the brain mechanisms involved. Now, research in fruit flies has uncovered a role for two specific brain proteins that are necessary during brain development to prevent seizures.

Ҵý: Direct-Acting Oral Anticoagulant and Antiseizure Medication Interactions: A Gray Zone in Epilepsy Treatment
Released: 17-Apr-2025 8:35 AM EDT
Direct-Acting Oral Anticoagulant and Antiseizure Medication Interactions: A Gray Zone in Epilepsy Treatment
International League Against Epilepsy

As many as 10% of people with epilepsy taking antiseizure medications also take medications to lower the risk of blood clots. Many are prescribed direct-acting oral anticoagulants, or DOACs. But how DOACs interact with antiseizure medications, particularly newer-generation medications, is still not clear.

Ҵý: Genetic Epilepsies: How Are Epilepsy Genes Discovered?
Released: 17-Apr-2025 8:15 AM EDT
Genetic Epilepsies: How Are Epilepsy Genes Discovered?
International League Against Epilepsy

Hundreds of genes have been associated with epilepsy. How are these genes discovered, and how can gene discovery be used to shape treatment strategies?

Released: 15-Apr-2025 8:10 AM EDT
Cadwell Makes a Strategic Investment in Seer Medical to Expand Home-Based Epilepsy Diagnostics
Cadwell Industries, Inc.

Cadwell Industries, Inc., a global leader in neurodiagnostic, neuromonitoring, and sleep solutions, today announced its strategic investment in Seer Medical, a Melbourne, Australia-based company specializing in home-based epilepsy diagnostics. The investment was made in partnership with investors Breakthrough Victoria and TrialCap.

Released: 14-Apr-2025 4:00 PM EDT
Children’s Hospital of Philadelphia Researchers Chart Natural History of Patients with SCN8A-Related Disorders
Children's Hospital of Philadelphia

Researchers have completed a comprehensive natural history study of SCN8A-related disorders, which represent a spectrum of neurological symptoms. The study, using retrospective clinical information analyzed through novel data analysis methods, revealed a range of seizure types and neurodevelopmental features, and identifies potential targets for future clinical trials.

Released: 10-Apr-2025 9:25 AM EDT
Estudio: La estimulación cerebral profunda personalizada podría tratar la epilepsia resistente a los fármacos
Mayo Clinic

Un estudio publicado en Brain Communications destaca un nuevo enfoque para el tratamiento de la epilepsia resistente a los medicamentos. Los investigadores de Mayo Clinic han desarrollado una plataforma innovadora de estimulación cerebral profunda (DBS, del inglés Deep Brain Stimulation) que se ha utilizado no solo para reducir las convulsiones, sino también para mejorar la memoria y el sueño, dos desafíos comunes para los pacientes con epilepsia.

Released: 10-Apr-2025 9:15 AM EDT
Estudo: Estimulação cerebral profunda personalizada pode tratar epilepsia resistente a medicamentos
Mayo Clinic

Um estudo publicado na Brain Communications destaca uma nova abordagem para o tratamento da epilepsia resistente a medicamentos. Pesquisadores da Mayo Clinic desenvolveram uma plataforma inovadora de estimulação cerebral profunda ((DBS, do inglês Deep Brain Stimulation) que foi utilizada não apenas para reduzir as crises, mas também para melhorar a memória e o sono — dois desafios comuns para pacientes com epilepsia.

Released: 10-Apr-2025 12:05 AM EDT
دراسة جديدة في مجلة Brain Communications تتوصل إلى أن التحفيز العميق المخصَّص للدماغ يُظهر نتائج واعدة في علاج الصرع المقاوم للأدوية
Mayo Clinic

روتشستر، ولاية مينيسوتا — تسلِّط دراسة جديدة نُشرت في مجلة اتصالات الدماغ (Brain Communications) الضوء على طريقة جديدة لعلاج الصرع المقاوم للأدوية. طوّر الباحثون في مايو كلينك منصة مبتكرة للتحفيز العميق للدماغ والتي استُخدمت ليس فقط لتقليل النوبات، ولكن أيضًا لتحسين الذاكرة والنوم — وهما تحديان شائعان لمرضى الصرع.

Released: 7-Apr-2025 2:50 PM EDT
New Study in Brain Communications Finds Personalized Deep Brain Stimulation Shows Promise for Drug-Resistant Epilepsy
Mayo Clinic

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform that was used to not only reduce seizures, but also improve memory and sleep — two common challenges for patients with epilepsy.

Ҵý: Mayo Clinic Researchers Lead Transformative Shift Toward Neurorestorative Treatment Strategies for Most Severe Forms of Epilepsy
Released: 2-Apr-2025 8:25 PM EDT
Mayo Clinic Researchers Lead Transformative Shift Toward Neurorestorative Treatment Strategies for Most Severe Forms of Epilepsy
Mayo Clinic

Mayo Clinic is taking epilepsy research in a bold new direction, exploring treatment approaches to help patients living with the most severe and difficult-to-treat forms of epilepsy. About 50 million people worldwide are impacted by epilepsy. Approximately 30% of patients, or about 15 million people, suffer with drug-resistant epilepsy (DRE).

Ҵý: Brain Channels ‘Stopped in Time’ Reveal Chemical Flow That Enables Learning and Thinking
Released: 28-Mar-2025 6:45 PM EDT
Brain Channels ‘Stopped in Time’ Reveal Chemical Flow That Enables Learning and Thinking
Johns Hopkins Medicine

A study led by Johns Hopkins Medicine researchers could advance the development of new drugs that block or open such signaling channels to treat conditions as varied as epilepsy and some intellectual disorders.

Ҵý: UTHealth Houston Welcomes First Patient to Pioneering Telehealth Epilepsy Clinic
Released: 25-Mar-2025 10:00 AM EDT
UTHealth Houston Welcomes First Patient to Pioneering Telehealth Epilepsy Clinic
University of Texas Health Science Center at Houston

UTHealth Houston is proud to announce the successful opening and first online patient visit at its groundbreaking Telehealth Precision Genetic Counseling for Epilepsy and Neurodevelopmental Disorders, a state-of-the-art telehealth initiative aimed at transforming the management of epilepsy and neurodevelopmental disorders through personalized genetic insights and virtual health care.

Ҵý: Genetic Testing for Epilepsy Surgery: Dr. Pat Moloney
Released: 24-Mar-2025 8:05 PM EDT
Genetic Testing for Epilepsy Surgery: Dr. Pat Moloney
International League Against Epilepsy

In the second episode of our genetics and epilepsy series, Sharp Waves explores how genetic insights can inform considerations and outcomes of epilepsy surgery. Dr. Alina Ivaniuk interviews Dr. Patrick Moloney, currently an epilepsy genomics fellow at the Chalfont Center for Epilepsy at University College London.

Ҵý: Recommandations consensuelles sur la façon de gérer l'épilepsie avec myoclonie des paupières (syndrome de Jeavons)
Released: 24-Mar-2025 7:55 PM EDT
Recommandations consensuelles sur la façon de gérer l'épilepsie avec myoclonie des paupières (syndrome de Jeavons)
International League Against Epilepsy

L’EEM est un syndrome d’épilepsie généralisée caractérisé par une triade de caractéristiques cliniques : crises induites par la fermeture de l’œil ou modifications de l’EEG, myoclonie des paupières avec ou sans crises d’absence et photosensibilité. Il apparaît principalement chez les femmes. Des lignes directrices consensuelles sur la présentation clinique, l’évaluation et la prise en charge des ESEE ont récemment été publiées dans Epilepsia.

Ҵý: cannabidiol_500x500.jpg
Released: 20-Mar-2025 12:00 PM EDT
New Cannabis Formula Will Help Epilepsy, Multiple Sclerosis Sufferers
University of South Australia

Scientists at the University of South Australia have come up with an innovative solution to improve the effectiveness of cannabidiol to treat epilepsy, multiple sclerosis and other ...



close
1.91766